XTL Biopharmaceuticals Ltd. (XTLB)
NASDAQ: XTLB · Real-Time Price · USD
1.890
-0.210 (-10.00%)
Dec 30, 2024, 9:30 AM EST - Market open
XTL Biopharmaceuticals Market Cap
XTL Biopharmaceuticals has a market cap or net worth of $22.79 million as of December 30, 2024. Its market cap has increased by 327.94% in one year.
Market Cap
22.79M
Enterprise Value
20.45M
1-Year Change
327.94%
Ranking
Category
Stock Price
$1.89
Market Cap Chart
Since August 31, 2005, XTL Biopharmaceuticals's market cap has decreased from $179.98M to $22.79M, a decrease of -87.34%. That is a compound annual growth rate of -10.13%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 705.19B |
| UnitedHealth Group | 469.34B |
| Novo Nordisk | 393.39B |
| Johnson & Johnson | 349.23B |
| AbbVie | 314.57B |
| Merck & Co. | 252.20B |
| AstraZeneca | 204.17B |
| Thermo Fisher Scientific | 201.22B |